FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Todd DeFor

Research Profile

Disorders

Procedures

Concepts & Ideas

Living Beings

Physiology

Graft Survival

Co-author Network

Publications

TOP 3
Osamah Aldoss; John L Bass; Todd E DeFor; Daniel H Gruenstein; Julia Steinberger; Jakub Tolar; Michael R Verneris; Yan Zhang; Paul J Orchard
Pericardial effusion after pediatric hematopoietic cell transplant.
Margaret L MacMillan; Todd E DeFor; Daniel J Weisdorf
What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score.
Daniel Weisdorf; David Porter; Edmond WALLER; Claudio Anasetti; Sarah Cooley; Julie Curtsinger; Todd E DeFor; Steven Devine; John DiPersio; William Drobyski; Sherif S Farag; Todd A Fehniger; Michael Haagenson; Jeffrey Miller
T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Todd DeFor (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Osamah Aldoss; John L Bass; Todd E DeFor; Daniel H Gruenstein; Julia Steinberger; Jakub Tolar; Michael R Verneris; Yan Zhang; Paul J Orchard
Pericardial effusion after pediatric hematopoietic cell transplant.
Pediatric transplantation 2013;17(3):294-9.
2012: Margaret L MacMillan; Todd E DeFor; Daniel J Weisdorf
What predicts high risk acute graft-versus-host disease (GVHD) at onset?: identification of those at highest risk by a novel acute GVHD risk score.
British journal of haematology 2012;157(6):732-41.
2012: Daniel Weisdorf; David Porter; Edmond WALLER; Claudio Anasetti; Sarah Cooley; Julie Curtsinger; Todd E DeFor; Steven Devine; John DiPersio; William Drobyski; Sherif S Farag; Todd A Fehniger; Michael Haagenson; Jeffrey Miller
T cell-depleted partial matched unrelated donor transplant for advanced myeloid malignancy: KIR ligand mismatch and outcome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(6):937-43.
2012: P Ramirez; Michael verneris; John E Wagner; Daniel J Weisdorf; Todd E DeFor; Philip B McGlave; David H McKenna; Jeffrey S Miller; Bruce R Blazar; Claudio G Brunstein
Factors predicting single-unit predominance after double umbilical cord blood transplantation.
Bone marrow transplantation 2012;47(6):799-803.
2011: Claudio G Brunstein; Todd E DeFor; David Maurer; Jeffrey S Miller; Harriet Noreen; John E Wagner
Anti-HLA antibodies in double umbilical cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(11):1704-8.
2011: Betul Oran; John E Wagner; Daniel J Weisdorf; Todd E DeFor; Claudio G Brunstein
Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(9):1327-34.
2011: Weston P Miller; David Nascene; Todd E DeFor; Julie Eisengart; Teresa Kivisto; Kara Leiser; Troy Lund; Gerald V Raymond; Steven M Rothman; Jakub Tolar; Richard S Ziegler; Paul J Orchard
Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.
Blood 2011;118(7):1971-8.
2011: Erica D Warlick; Mukta Aurora; Veronika Bachanova; Bruce R Blazar; Claudio G Brunstein; Linda J Burns; Qing Cao; Sarah Cooley; Todd E DeFor; Kathryn E Dusenbery; Dan Kaufman; Margaret L MacMillan; Navneet S Majhail; Brian McClune; Philip McGlave; Jeffrey Miller; Betul Oran; Arne Slungaard; Marcie Tomblyn; Gregory Vercellotti; Michael verneris; John Wagner; Daniel J Weisdorf
Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(7):1025-32.
2011: P Ramírez; Claudio G Brunstein; Todd E DeFor; B Miller; Daniel Weisdorf
Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival.
Bone marrow transplantation 2011;46(7):981-6.
2011: Angela R Smith; Navneet S Majhail; Margaret L MacMillan; Todd E DeFor; Sonata Jodele; Leslie E Lehmann; Robert Krance; Stella M Davies
Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients.
Blood 2011;117(9):2728-34.
2011: Claudio G Brunstein; Jeffrey S Miller; Qing Cao; David H McKenna; Keli L Hippen; Julie Curtsinger; Todd E DeFor; Bruce L Levine; Carl H June; Pablo Rubinstein; Philip B McGlave; Bruce R Blazar; John E Wagner
Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.
Blood 2011;117(3):1061-70.
2010: Claudio G Brunstein; Jonathan A Gutman; Daniel J Weisdorf; Ann E Woolfrey; Todd E DeFor; Theodore A Gooley; Michael R Verneris; Frederick R Appelbaum; John E Wagner; Colleen Delaney
Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.
Blood 2010;116(22):4693-9.
2010: Margaret L MacMillan; Todd E DeFor; Daniel J Weisdorf
The best endpoint for acute GVHD treatment trials.
Blood 2010;115(26):5412-7.
2010: Paul J Orchard; Carlos Milla; Elizabeth Braunlin; Todd E DeFor; Kendra J Bjoraker; Bruce R Blazar; Charles Peters; J Wagner; Jakub Tolar
Pre-transplant risk factors affecting outcome in Hurler syndrome.
Bone marrow transplantation 2010;45(7):1239-46.
2010: Todd E DeFor; Navneet S Majhail; Daniel J Weisdorf; Claudio G Brunstein; S McAvoy; Mukta Arora; Chap T Le
A modified comorbidity index for hematopoietic cell transplantation.
Bone marrow transplantation 2010;45(5):933-8.
2010: Shawn S Groth; Beth A Virnig; Bryan A Whitson; Todd E DeFor; Zhong-Ze Li; Todd M Tuttle; Michael A Maddaus
Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database.
The Journal of thoracic and cardiovascular surgery 2010;139(3):612-20.
2010: Jill C Beck; John E Wagner; Todd E DeFor; Claudio G Brunstein; Mark R Schleiss; Jo-Anne Young; Daniel H Weisdorf; Sarah Cooley; Jeffrey S Miller; Michael verneris
Impact of cytomegalovirus (CMV) reactivation after umbilical cord blood transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(2):215-22.
2009: Michael verneris; Claudio G Brunstein; Juliet N Barker; Margaret L MacMillan; Todd E DeFor; David H McKenna; Michael J Burke; Bruce R Blazar; Jeffrey S Miller; Philip B McGlave; Daniel J Weisdorf; John E Wagner
Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.
Blood 2009;114(19):4293-9.
2009: Angela R Smith; K Scott Baker; Todd E DeFor; Michael verneris; John E Wagner; Margaret L MacMillan
Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1086-93.
2009: Michael B Tomblyn; Mukta Arora; K Scott Baker; Bruce R Blazar; Claudio G Brunstein; Linda J Burns; Todd E DeFor; Kathryn E Dusenbery; Dan S Kaufman; John H Kersey; Margaret L MacMillan; Philip B McGlave; Jeffrey S Miller; Paul J Orchard; Arne Slungaard; Marcie R Tomblyn; Gregory M Vercellotti; Michael verneris; John E Wagner; Daniel J Weisdorf
Myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia: analysis of graft sources and long-term outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(22):3634-41.
2009: Pamala Jacobson; S F El-Massah; John Rogosheske; A Kerr; J Long-Boyle; Todd E DeFor; C Jennissen; Claudio G Brunstein; J Wagner; M Tomblyn; Daniel Weisdorf
Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation.
Bone marrow transplantation 2009;44(2):113-20.
2009: Claudio G Brunstein; Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; D McKenna; S Y Chong; Jeffrey S Miller; Philip B McGlave; John E Wagner
Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units.
Bone marrow transplantation 2009;43(12):935-40.
2009: Claudio G Brunstein; John E Wagner; Daniel J Weisdorf; Sarah Cooley; Harriet Noreen; Juliet N Barker; Todd E DeFor; Michael verneris; Bruce R Blazar; Jeffrey S Miller
Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity.
Blood 2009;113(22):5628-34.
2009: Navneet S Majhail; Todd E DeFor; Hillard M Lazarus; Linda J Burns
Iron-overload after autologous hematopoietic cell transplantation.
Leukemia research 2009;33(4):578-9.
2009: Veronika Bachanova; Michael verneris; Todd E DeFor; Claudio G Brunstein; Daniel J Weisdorf
Prolonged survival in adults with acute lymphoblastic leukemia after reduced-intensity conditioning with cord blood or sibling donor transplantation.
Blood 2009;113(13):2902-5.
2009: Margaret L MacMillan; Daniel J Weisdorf; Claudio G Brunstein; Qing Cao; Todd E DeFor; Michael verneris; Bruce R Blazar; John E Wagner
Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors.
Blood 2009;113(11):2410-5.
2009: Margaret L MacMillan; Bruce R Blazar; Todd E DeFor; John E Wagner
Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial.
Bone marrow transplantation 2009;43(6):447-54.
2009: V Bachanova; Claudio G Brunstein; Linda J Burns; Jeffrey S Miller; X Luo; Todd E DeFor; J-A H Young; Daniel J Weisdorf; M Tomblyn
Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma.
Bone marrow transplantation 2009;43(3):237-44.
2009: Erica D Warlick; Adina Cioc; Todd E DeFor; Michelle Dolan; Daniel Weisdorf
Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1):30-8.
2009: Mukta Arora; S Nagaraj; J Witte; Todd E DeFor; Margaret L MacMillan; Linda J Burns; Daniel J Weisdorf
New classification of chronic GVHD: added clarity from the consensus diagnoses.
Bone marrow transplantation 2009;43(2):149-53.
2008: Priya Kumar; Todd E DeFor; Claudio G Brunstein; Juliet N Barker; John E Wagner; Daniel J Weisdorf; Linda J Burns
Allogeneic hematopoietic stem cell transplantation in adult acute lymphocytic leukemia: impact of donor source on survival.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1394-400.
2008: John E Levine; Bruce R Blazar; Todd E DeFor; James L M Ferrara; Daniel J Weisdorf
Long-term follow-up of a phase I/II randomized, placebo-controlled trial of palifermin to prevent graft-versus-host disease (GVHD) after related donor allogeneic hematopoietic cell transplantation (HCT).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(9):1017-21.
2008: Navneet S Majhail; Claudio G Brunstein; Sarah McAvoy; Todd E DeFor; Ahmed Al-Hazzouri; Daniela Setubal; Mukta Arora; Chap T Le; John E Wagner; Daniel J Weisdorf
Does the hematopoietic cell transplantation specific comorbidity index predict transplant outcomes? A validation study in a large cohort of umbilical cord blood and matched related donor transplants.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(9):985-92.
2008: Navneet S Majhail; Todd E DeFor; Hillard M Lazarus; Linda J Burns
High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):790-4.
2008: Paul D Harker-Murray; Avis J Thomas; John E Wagner; Daniel Weisdorf; Xianghua Luo; Todd E DeFor; Michael verneris; Kathryn E Dusenbery; Margaret L MacMillan; Jakub Tolar; K Scott Baker; Paul J Orchard
Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(6):685-92.
2008: Marcie Tomblyn; Claudio G Brunstein; Linda J Burns; Jeffrey S Miller; Margaret L MacMillan; Todd E DeFor; Daniel J Weisdorf
Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(5):538-45.
2008: Pamala Jacobson; Jaiyin Huang; Nancy Rydholm; Myhang Tran; Todd E DeFor; Jakub Tolar; Paul J Orchard
Higher mycophenolate dose requirements in children undergoing hematopoietic cell transplant (HCT).
Journal of clinical pharmacology 2008;48(4):485-94.
2007: Claudio G Brunstein; Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Jeffrey S Miller; Bruce R Blazar; Philip B McGlave; John E Wagner
Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.
Blood 2007;110(8):3064-70.
2007: Mukta Arora; Sriharsha Nagaraj; John E Wagner; Juliet N Barker; Claudio G Brunstein; Linda J Burns; Todd E DeFor; Margaret L McMillan; Jeffrey S Miller; Daniel J Weisdorf
Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(10):1145-52.
2007: Catherine M Flynn; Betsy Hirsch; Todd E DeFor; Juliet N Barker; Jeffrey S Miller; John E Wagner; Bruce R Blazar; Linda J Burns; Margaret L MacMillan; Mukta Arora; Daniel Weisdorf
Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysis.
American journal of hematology 2007;82(10):867-72.
2007: Jeffrey S Miller; Daniel J Weisdorf; Linda J Burns; Arne Slungaard; John E Wagner; Michael verneris; Sarah Cooley; Rosanna Wangen; Susan K Fautsch; Roby Nicklow; Todd E DeFor; Bruce R Blazar
Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone.
Blood 2007;110(7):2761-3.
2007: Todd E DeFor; Linda J Burns; Eva-Maria A Gold; Daniel J Weisdorf
A randomized trial of the effect of a walking regimen on the functional status of 100 adult allogeneic donor hematopoietic cell transplant patients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(8):948-55.
2007: Rachel E Lerner; William Thomas; Todd E DeFor; Daniel J Weisdorf; Linda J Burns
The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):486-92.
2007: M Markova; Juliet N Barker; Jeffrey S Miller; Mukta Arora; John E Wagner; Linda J Burns; Margaret L MacMillan; D Douek; Todd E DeFor; Y Tan; Tanya L Repka; Bruce R Blazar; Daniel J Weisdorf
Fludarabine vs cladribine plus busulfan and low-dose TBI as reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation: a prospective randomized trial.
Bone marrow transplantation 2007;39(4):193-9.
2007: Pamala Jacobson; Kathleen Green; John Rogosheske; Claudio G Brunstein; Breta Ebeling; Todd E DeFor; Philip B McGlave; Daniel Weisdorf
Highly variable mycophenolate mofetil bioavailability following nonmyeloablative hematopoietic cell transplantation.
Journal of clinical pharmacology 2007;47(1):6-12.
2006: Navneet S Majhail; K Parks; Todd E DeFor; Daniel J Weisdorf
Alveolar hemorrhage following allogeneic hematopoietic cell transplantation using reduced-intensity conditioning.
Bone marrow transplantation 2006;38(11):765-8.
2006: Bruce R Blazar; Daniel J Weisdorf; Todd E DeFor; Anne Goldman; Thomas Braun; Samuel Michael Silver; James L M Ferrara
Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT).
Blood 2006;108(9):3216-22.
2006: Claudio G Brunstein; Daniel J Weisdorf; Todd E DeFor; Juliet N Barker; Jakub Tolar; Jo-Anne H van Burik; John E Wagner
Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.
Blood 2006;108(8):2874-80.
2006: Navneet S Majhail; Daniel J Weisdorf; Todd E DeFor; Jeffrey S Miller; Philip B McGlave; Arne Slungaard; Mukta Arora; Norma K C Ramsay; Paul J Orchard; Margaret L MacMillan; Linda J Burns
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(10):1065-72.
2006: Navneet S Majhail; Kristi Parks; Todd E DeFor; Daniel J Weisdorf
Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(10):1038-46.
2006: Khalid Khan; Sarah Jane Schwarzenberg; Harvey Sharp; Jose Jessurun; H Evin Gulbahce; Todd E DeFor; Rajaram Nagarajan
Diagnostic endoscopy in children after hematopoietic stem cell transplantation.
Gastrointestinal endoscopy 2006;64(3):379-85; quiz 389-92.
2006: Navneet S Majhail; Daniel J Weisdorf; John E Wagner; Todd E DeFor; Claudio G Brunstein; Linda J Burns
Comparable results of umbilical cord blood and HLA-matched sibling donor hematopoietic stem cell transplantation after reduced-intensity preparative regimen for advanced Hodgkin lymphoma.
Blood 2006;107(9):3804-7.
2006: Poh-Lin Tan; John E Wagner; Arleen D Auerbach; Todd E DeFor; Arne Slungaard; Margaret L MacMillan
Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
Pediatric blood & cancer 2006;46(5):630-6.
2006: Christopher J Fraser; Brenda J Weigel; John P Perentesis; Kathryn E Dusenbery; Todd E DeFor; K Scott Baker; Michael verneris
Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumors.
Bone marrow transplantation 2006;37(2):175-81.
2005: Stella M Davies; Gretchen A Radloff; Todd E DeFor; Orna Levran; Sat Dev Batish; Helmut Hanenberg; Arleen D Auerbach
GST genotype may modify clinical phenotype in patients with Fanconi anaemia.
British journal of haematology 2005;131(1):118-22.
2005: M Arora; Philip B McGlave; Linda J Burns; Jeffrey S Miller; J N Barke; Todd E DeFor; Daniel J Weisdorf
Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma.
Bone marrow transplantation 2005;35(12):1133-40.
2005: Juliet N Barker; Rachael E Hough; Jo-Anne H van Burik; Todd E DeFor; Margaret L MacMillan; Michele R O'Brien; John E Wagner
Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(5):362-70.
2005: Jeffrey S Miller; Yvette Soignier; Angela Panoskaltsis-Mortari; Sarah A McNearney; Gong H Yun; Susan K Fautsch; David McKenna; Chap Le; Todd E DeFor; Linda J Burns; Paul J Orchard; Bruce R Blazar; John E Wagner; Arne Slungaard; Daniel J Weisdorf; Ian J Okazaki; Philip B McGlave
Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer.
Blood 2005;105(8):3051-7.
2005: Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Bruce R Blazar; Philip B McGlave; Jeffrey S Miller; Catherine M Verfaillie; John E Wagner
Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.
Blood 2005;105(3):1343-7.
2005: Mark Eikenberry; Hana Bartakova; Todd E DeFor; Imad Y Haddad; Norma K C Ramsay; Bruce R Blazar; Carlos Milla; David N Cornfield
Natural history of pulmonary complications in children after bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(1):56-64.
2004: Tracey A O'Brien; Ted Eastlund; Charles Peters; Joseph P Neglia; Todd E DeFor; Norma K C Ramsay; K Scott Baker
Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases.
British journal of haematology 2004;127(1):67-75.
2004: Sandra M P Cardoso; Todd E DeFor; Louise A Tilley; Jeffrey L Bidwell; Daniel J Weisdorf; Margaret L MacMillan
Patient interleukin-18 GCG haplotype associates with improved survival and decreased transplant-related mortality after unrelated-donor bone marrow transplantation.
British journal of haematology 2004;126(5):704-10.
2004: Charles Peters; Lawrence Charnas; Ye Tan; Richard S Ziegler; Elsa G Shapiro; Todd E DeFor; Satkiran S Grewal; Paul J Orchard; Susan L Abel; Anne I Goldman; Norma K C Ramsay; Kathryn E Dusenbery; Daniel J Loes; Lawrence A Lockman; Shunichi Kato; Patrick R Aubourg; Hugo W Moser; William Krivit
Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999.
Blood 2004;104(3):881-8.
2004: Mukta Arora; Linda J Burns; Juliet N Barker; Jeffrey S Miller; Todd E DeFor; Adebayo B Olujohungbe; Daniel J Weisdorf
Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(6):395-404.
2004: Leigh J Keen; Todd E DeFor; Jeffrey L Bidwell; Stella M Davies; Benjamin A Bradley; Jill M Hows
Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation.
Blood 2004;103(9):3599-602.
2004: Elena G Chiorean; Todd E DeFor; Daniel J Weisdorf; Bruce R Blazar; Philip B McGlave; Linda J Burns; Charlotte Brown; Jeffrey S Miller
Donor chimerism does not predict response to donor lymphocyte infusion for relapsed chronic myelogenous leukemia after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):171-7.
2003: Margaret L MacMillan; Gretchen A Radloff; William R Kiffmeyer; Todd E DeFor; Daniel J Weisdorf; Stella M Davies
High-producer interleukin-2 genotype increases risk for acute graft-versus-host disease after unrelated donor bone marrow transplantation.
Transplantation 2003;76(12):1758-62.
2003: Arkadiusz Z Dudek; Hemchandra Mahaseth; Todd E DeFor; Daniel J Weisdorf
Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(10):657-66.
2003: Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Bruce R Blazar; Jeffrey S Miller; John E Wagner
Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.
Blood 2003;102(5):1915-9.
2003: Linda J Burns; Daniel J Weisdorf; Todd E DeFor; David H Vesole; Tanya L Repka; Bruce R Blazar; S R Burger; A Panoskaltsis-Mortari; Carolyn Keever-Taylor; M-J Zhang; Jeffrey S Miller
IL-2-based immunotherapy after autologous transplantation for lymphoma and breast cancer induces immune activation and cytokine release: a phase I/II trial.
Bone marrow transplantation 2003;32(2):177-86.
2003: Margaret L MacMillan; Gretchen A Radloff; Todd E DeFor; Daniel J Weisdorf; Stella M Davies
Interleukin-1 genotype and outcome of unrelated donor bone marrow transplantation.
British journal of haematology 2003;121(4):597-604.
2003: K Scott Baker; Todd E DeFor; Linda J Burns; Norma K C Ramsay; Joseph P Neglia; Leslie L Robison
New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1352-8.
2003: Daniel Anderson; Todd E DeFor; Linda J Burns; Philip B McGlave; Jeffrey Miller; John Wagner; Daniel Weisdorf
A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(1):52-9.
2003: Mukta Arora; Linda J Burns; Stella M Davies; Margaret L MacMillan; Todd E DeFor; Wesley J Miller; Daniel J Weisdorf
Chronic graft-versus-host disease: a prospective cohort study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(1):38-45.
2002: Linda J Burns; Wesley J Miller; C Kandaswamy; Todd E DeFor; Margaret L MacMillan; Jo-Anne H van Burik; Daniel J Weisdorf
Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
Bone marrow transplantation 2002;30(12):945-51.
2002: Stella M Davies; Loredana Ruggieri; Todd E DeFor; John E Wagner; Daniel J Weisdorf; Jeffrey S Miller; Andrea Velardi; Bruce R Blazar
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor.
Blood 2002;100(10):3825-7.
2002: John E Wagner; Juliet N Barker; Todd E DeFor; K Scott Baker; Bruce R Blazar; Cindy Eide; Anne Goldman; John H Kersey; William Krivit; Margaret L MacMillan; Paul J Orchard; Charles Peters; Daniel J Weisdorf; Norma K C Ramsay; Stella M Davies
Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.
Blood 2002;100(5):1611-8.
2002: Juliet N Barker; Stella M Davies; Todd E DeFor; Linda J Burns; Philip B McGlave; Jeffrey S Miller; Daniel J Weisdorf
Determinants of survival after human leucocyte antigen-matched unrelated donor bone marrow transplantation in adults.
British journal of haematology 2002;118(1):101-7.
2002: Margaret L MacMillan; Jesse Goodman; Todd E DeFor; Daniel J Weisdorf
Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy.
The American journal of medicine 2002;112(5):369-79.
2002: Satkiran S Grewal; William Krivit; Todd E DeFor; Elsa G Shapiro; Paul J Orchard; S L Abel; Lawrence A Lockman; Richard S Ziegler; Kathryn E Dusenbery; Charles Peters
Outcome of second hematopoietic cell transplantation in Hurler syndrome.
Bone marrow transplantation 2002;29(6):491-6.
2002: Margaret L MacMillan; Daniel J Weisdorf; John E Wagner; Todd E DeFor; Linda J Burns; Norma K C Ramsay; Stella M Davies; Bruce R Blazar
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(7):387-94.
2002: Juliet N Barker; Timothy P Krepski; Todd E DeFor; Stella M Davies; John E Wagner; Daniel J Weisdorf
Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(5):257-60.
2002: Margaret L MacMillan; Daniel J Weisdorf; Stella M Davies; Todd E DeFor; Linda J Burns; Norma K C Ramsay; John E Wagner; Bruce R Blazar
Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(1):40-6.
2001: Juliet N Barker; S M Davies; Todd E DeFor; Norma K C Ramsay; Daniel J Weisdorf; John E Wagner
Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
Blood 2001;97(10):2957-61.
2001: Pamala Jacobson; J J Park; Todd E DeFor; M Thrall; Susan Abel; William Krivit; Charles Peters
Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation.
Bone marrow transplantation 2001;27(8):855-61.
2001: S M Davies; Todd E DeFor; Philip B McGlave; J S Miller; C M Verfaillie; John E Wagner; Daniel J Weisdorf
Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors.
The American journal of medicine 2001;110(5):339-46.
2001: Jo-Anne H van Burik; E J Lawatsch; Todd E DeFor; Daniel J Weisdorf
Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(12):674-9.
2001: Mukta Arora; John E Wagner; Stella M Davies; Bruce R Blazar; Todd E DeFor; Helen Enright; Wesley J Miller; D F Weisdorf
Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(5):265-73.
2000: M Eapen; Norma K C Ramsay; Ann C Mertens; Leslie L Robison; Todd E DeFor; Stella M Davies
Late outcomes after bone marrow transplant for aplastic anaemia.
British journal of haematology 2000;111(3):754-60.
2000: Paul V Browne; Daniel J Weisdorf; Todd E DeFor; Wesley J Miller; Stella M Davies; Alexandra H Filipovich; Philip B McGlave; Norma K C Ramsay; J Wagner; Helen Enright
Response to thalidomide therapy in refractory chronic graft-versus-host disease.
Bone marrow transplantation 2000;26(8):865-9.
2000: J D Lickliter; Philip B McGlave; Todd E DeFor; Jeffrey S Miller; Norma K C Ramsay; C M Verfaillie; Linda J Burns; John E Wagner; Ted Eastlund; Kathryn E Dusenbery; Daniel J Weisdorf
Matched-pair analysis of peripheral blood stem cells compared to marrow for allogeneic transplantation.
Bone marrow transplantation 2000;26(7):723-8.
2000: I D Lewis; Todd E DeFor; Daniel J Weisdorf
Increasing incidence of diffuse alveolar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy.
Bone marrow transplantation 2000;26(5):539-43.
2000: Margaret L MacMillan; Arleen D Auerbach; Stella M Davies; Todd E DeFor; AP Gillio; R Giller; R Harris; Mitchell S Cairo; Kathryn E Dusenbery; Betsy Hirsch; Norma K C Ramsay; Daniel J Weisdorf; John E Wagner
Haematopoietic cell transplantation in patients with Fanconi anaemia using alternate donors: results of a total body irradiation dose escalation trial.
British journal of haematology 2000;109(1):121-9.
2000: Daniel J Weisdorf; Todd E DeFor; J Nichol; A Panoskaltsis-Mortari; Bruce R Blazar
Thrombopoietic cytokines in relation to platelet recovery after bone marrow transplantation.
Bone marrow transplantation 2000;25(7):711-5.
2000: Louise Cragg; B R Blazar; Todd E DeFor; N Kolatker; Wesley J Miller; John H Kersey; M Ramsay; Philip B McGlave; Alexandra H Filipovich; Daniel Weisdorf
A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(4A):441-7.
2000: Linda J Burns; Daniel J Weisdorf; Todd E DeFor; Tanya L Repka; K M Ogle; C Hummer; Jeffrey S Miller
Enhancement of the anti-tumor activity of a peripheral blood progenitor cell graft by mobilization with interleukin 2 plus granulocyte colony-stimulating factor in patients with advanced breast cancer.
Experimental hematology 2000;28(1):96-103.
1999: J Perentesis; E Katsanis; Todd E DeFor; Joseph P Neglia; Norma K C Ramsay
Autologous stem cell transplantation for high-risk pediatric solid tumors.
Bone marrow transplantation 1999;24(6):609-15.
1999: Thomas G Gross; Michael Steinbuch; Todd E DeFor; R S Shapiro; Philip B McGlave; Norma K C Ramsay; John E Wagner; Alexandra H Filipovich
B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome.
Bone marrow transplantation 1999;23(3):251-8.
1999: Paul J Orchard; John Rogosheske; Linda J Burns; N Rydholm; H Larson; Todd E DeFor; Norma K C Ramsay; Daniel Weisdorf
A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(6):386-93.
1998: Catherine M Verfaillie; R Bhatia; Michael Steinbuch; Todd E DeFor; Betsy Hirsch; Jeffrey S Miller; Daniel Weisdorf; Philip B McGlave
Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cells.
Blood 1998;92(5):1820-31.
1998: C Arns da Cunha; Daniel Weisdorf; X O Shu; Todd E DeFor; J D Pastor; J R Johnson
Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxis.
Bone marrow transplantation 1998;21(2):173-80.
1997: M J Dugan; Todd E DeFor; Michael Steinbuch; Alexandra H Filipovich; Daniel J Weisdorf
ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival.
Annals of hematology 1997;75(1-2):41-6.
1997: Stella M Davies; John E Wagner; Todd E DeFor; Bruce R Blazar; E Katsanis; John H Kersey; Paul J Orchard; Philip B McGlave; Daniel J Weisdorf; Norma K C Ramsay
Unrelated donor bone marrow transplantation for children and adolescents with aplastic anaemia or myelodysplasia.
British journal of haematology 1997;96(4):749-56.
1996: H Enright; Stella M Davies; Todd E DeFor; X Shu; Daniel Weisdorf; Wesley J Miller; Norma K C Ramsay; D Arthur; Catherine M Verfaillie; J Miller; J Kersey; Philip B McGlave
Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.
Blood 1996;88(2):714-20.